Trial Profile
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs SUN 13834 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Asubio Pharmaceuticals
- 15 May 2014 New trial record